Abstract
The objective of this study was to investigate infection and sepsis in hospitalised children with systemic lupus erythematosus (SLE). Between 1991 and 2000 we reviewed 72 episodes of suspected infection in 42 children with SLE from all hospitalised children with SLE at a medical center in Taiwan. Data comprised clinical and laboratory characteristics of SLE at the time of infection. Infections were identified and categorised as minor or major. A total of 125 patients (110 girls, 15 boys) were admitted 557 times. Forty-two patients had infections, giving an infection rate of 33.6%. There were a total of 72 infections including 20 proven infections; 61 cases of these were minor infections and 11 cases of these were major infections (10 cases were sepsis). Four patients died because of sepsis. By univariate analysis, major infection (sepsis) was significantly associated with a high SLE disease activity index score, lower complement levels and higher anti-DNA titres. In conclusion, our data confirm that infection is common in hospitalised children with SLE. Sepsis, most frequent in major infections, is associated with disease activity and causes significant mortality. These facts should be borne in mind when children with SLE are hospitalised.
Similar content being viewed by others
References
Staples P, Gerding D, Decker J, Gordon R (1974) Incidence of infection in systemic lupus erythematous. Arthritis Rheum 17:1–10
Ginzler E, Diamond H, Kapland D, Weiner M, Schlesinger M (1978) Computer analysis of factors influencing frequency of infection in systemic lupus erythematous. Arthritis Rheum 21:37–44
Nived O, Sturfelt G, Wollheim F (1985) Systemic lupus erythematous and infection: a controlled and prospective study including an epidemiological group. QJM 55:271–287
Rosner S, Ginzler E, Diamond H, et al. (1982) A multicenter study of outcome in systemic lupus erythematous: II. Causes of death. Arthritis Rheum 25:612–617
Wallace D, Podell T, Weiner J, et al. (1981) Systemic lupus erythematous survival patterns. Experience with 609 patients. JAMA 245:934–938
Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematous. Am J Med 60:221–225
Ginzler EM, Diamond HS, Weiner M, et al. (1982) A multicenter study of outcome in systemic lupus erythematosus. 1. Entry variables as predictors of prognosis. Arthritis Rheum 25: 601–611
Jonsson H, Nived O, Sturfelt G (1989) Outcome in systemic lupus erythematous: A prospective study of patients from a defined population. Medicine (Baltimore) 68:141–150
Reveille JD, Bartolucci A, Alarcon GS (1990) Prognosis in systemic lupus erythematous: negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 33:37–48
Ward MM, Pyun E, Studenski S (1996) Mortality risk associated with specific clinical manifestations of systemic lupus erythematous. Arch Int Med 156:1337–1344
Duffy K, Duffy C, Gladman D (1991) Infection and disease activity in systemic lupus erythematous: a review of hospitalized patients. J Rheumatol 18:1180–1184
Kim W, Min J, Lee S, Park S, Kim M (1999) Causes of death in Korean patients with systemic lupus erythematous: a single center retrospective study. Clin Exp Rheumatol 17:539–545
Gudmundsson S, Steinsson K (1990) Systemic lupus erythematous in Iceland 1975–1984: a nationwide epidemiological study in an unselected population. J Rheumatol 17:1162–1167
Hellmann DB, Petri M, Whiting-O’Keefe Q (1987) Fetal infections in systemic lupus erythematous: the role of opportunistic organism. Medicine (Baltimore) 66:341–348
Tan E, Cohen A, Fries J, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematous (SLE). Arthritis Rheum 25:1271–1277
Isenberg D, Bacon B, Bombardier C, et al. (1989) Workshop report. Criteria for assessing disease activity in systemic lupus erythematous. J Rheumatol 16:1395–1396
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
Liang MH, Socher SA, Larson MG, Schur P (1989) Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematous. Arthritis Rheum 32:1107–1118
Gladman D, Goldsmith C, Urowitz M, et al. (1990) Sensitivity to change of 3 SLE disease activity indices: International validation (abstract). Arthritis Rheum [Suppl 9]:33:S82
Al-mayouf S, Al-jumaah S, Bahabris S, Al-eid W (2001) Infections associated with juvenile systemic lupus erythematosus. Clin Exp Rheumatol 19:748–750
Lacks S, White P (1990) Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 17:941–945
Pryor B, Bologna G, Kahl L (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematous. Arthritis Rheum 39:1475–1482
Lee P, Urowitz MB, Bookman AA, Koehler BE, Smythe HA, Ogryzlo MA (1977) Systemic lupus erythematous. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. QJM 46:1–32
Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematous. Arthritis Rheum 38:1492–1499
Studenski S, Allen NB, Caldwell DS, Rice JR, Polisson RP (1987) Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 30:1326–1332
Massardo R, Martinez M, Jacobelli S, et al. (1994) Survival of Chilean patients with systemic lupus erythematous. Semin Arthritis Rheum 24:1–11
Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematous. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, YS., Yang, YH., Lin, YT. et al. Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up. Clin Rheumatol 23, 235–238 (2004). https://doi.org/10.1007/s10067-004-0877-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-0877-8